The Biotech Ingredient Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Biotech Ingredient market has been experiencing steady growth. The market size was $59.9 billion in 2024, and it is projected to increase to $63.86 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.6%.
The Biotech Ingredient market is projected to grow to a size of $83.5 billion in 2029, with a compound annual growth rate (CAGR) of 6.9%.
Download Your Free Sample of the 2025 Biotech Ingredient Market Report and Uncover Key Trends Now!The key drivers in the biotech ingredient market are:
• Increase in focus on personalized nutrition
• Expansion and growth of cell-based meat production
• Advancements in the development of therapeutic biotech ingredients
• Prominence of bio ingredients in waste reduction and shift towards bioplastics.
The biotech ingredient market covered in this report is segmented –
1) By Type: Active Pharmaceutical Ingredients, Biosimilars
2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems
3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications
The key trends in the biotech ingredient market are:
• Personalized nutrition and cell-based meat production are key trends shaping the biotech ingredient market.
• The development of therapeutic biotech ingredients is another emerging trend.
• Biotech ingredients are increasingly being used for waste reduction and clean energy production.
• There is a global emphasis on biodiversity conservation, which is influencing the biotech ingredient market.
Major companies in the biotech ingredient market are:
• Merck & Co. Inc.
• Sanofi S.A.
• AbbVie Inc.
• International Flavors & Fragrance (IFF) Inc.
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan Inc.
• Boehringer Ingelheim International GmbH.
• AstraZeneca plc.
• Givaudan
• Firmenich SA
• Amyris Inc.
• Advanced BioTech
• Sollice Biotech
• Novocap S.A.
• Eli Lilly
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche AG
• Biogen Inc.
• Amgen Inc.
• Johnson & Johnson
• Genentech Inc.
• Regeneron Pharmaceuticals Inc.
• Vertex Pharmaceuticals Incorporated
• Alexion Pharmaceuticals Inc.
• Celgene Corporation
• Gilead Sciences Inc.
• BioMarin Pharmaceutical Inc.
• Incyte Corporation
• Seattle Genetics Inc.
• Alnylam Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Moderna Inc.
• Editas Medicine Inc.
• Intellia Therapeutics Inc.
• Sangamo Therapeutics Inc.
• Bluebird Bio Inc.
• Spark Therapeutics Inc.
Europe was the largest region in the biotech ingredient market in 2024